VSTM - Verastem Inc
6.39
0.090 1.408%
Share volume: 899,699
Last Updated: 03-10-2026
Pharmaceutical Products/Pharmaceutical Preparations:
3.17%
PREVIOUS CLOSE
CHG
CHG%
$6.30
0.09
0.01%
View ratios
| Fiscal Date | 03-31-2024 | 09-30-2024 | 12-31-2024 | 03-31-2025 | 06-30-2025 | 09-30-2025 | 12-31-2025 | |
|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | |
| Report Date | 05-09-2024 | 11-06-2024 | 03-20-2025 | 05-13-2025 | 08-07-2025 | 11-04-2025 | 03-04-2026 | |
| Total revenue | 10.000 M | 0.000 | 0.000 | 0.000 | 2.137 M | 11.242 M | 17.535 M | |
| Cost of revenue | 0.000 | 0.000 | 0.000 | 0.000 | 318.000 K | 1.670 M | 2.612 M | |
| Gross profit | 10.000 M | 0.000 | 0.000 | 0.000 | 1.819 M | 9.572 M | 14.923 M | |
| -100.00% | nan% | inf% | 426.22% | 55.90% | ||||
| Operating expenses | 28.277 M | 37.030 M | 0.000 | 44.174 M | 45.455 M | 49.997 M | 56.119 M | |
| Selling general and admin | 10.215 M | 12.276 M | 0.000 | 15.022 M | 20.669 M | 21.008 M | 24.447 M | |
| Research and development | 18.062 M | 24.754 M | 0.000 | 29.152 M | 24.786 M | 28.989 M | 31.672 M | |
| Total expenses | 28.277 M | 37.030 M | 0.000 | 44.174 M | 45.583 M | 50.287 M | 56.399 M | |
| 30.95% | -100.00% | 3.19% | 10.32% | 12.15% | ||||
| Operating income | -18.277 M | -37.030 M | 0.000 | -44.174 M | -43.764 M | -40.715 M | -41.476 M | |
| Ebit | -18.277 M | -23.573 M | 0.000 | -51.045 M | -26.544 M | -99.381 M | -33.605 M | |
| Pretax income | -18.432 M | -23.890 M | 0.000 | 0.000 | 0.000 | 0.000 | -209.471 M | |
| 29.61% | -100.00% | nan% | nan% | inf% | ||||
| Income tax | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Net income basic | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Net income | -8.256 M | -23.967 M | 0.000 | -52.103 M | -25.934 M | -98.518 M | -32.916 M | |
| -190.30% | 100.00% | 50.23% | -279.88% | 66.59% |